For: |
Ángel GM, Paola VV, Froylan David MS, Lucía PB, Juan Mauricio VZ, María Fernanda NF, Guadalupe MM, Jorge Ignacio FC, Julia María ZV, Olynka VV, Ricardo CR, Rodolfo RP, Luis E MB, Josefina AG, Berenice RJ, Lizette PR, Malaquías LC, de Los Ángeles MM, Victoria BY, Ángeles EC, Guadalupe LC, Angelina LE, Elizabeth GL, Francisco J GP, Daniel CR. Fibroblast growth factor 21 is associated with increased serum total antioxidant capacity and oxidized lipoproteins in humans with different stages of chronic kidney disease. Ther Adv Endocrinol Metab 2021;12:20420188211001160. [PMID: 33854753 DOI: 10.1177/20420188211001160] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|